Ocean Biomedical reports new results validating tumor suppression with anti-Chi3L1 antibody: EF Hutton raises OCEA price target to $17 April 27, 2023
Ocean Biomedical co-founder Jonathan Kurtis presents detailed data on malaria vaccine at conference April 25, 2023
Ocean Biomedical co-founder Jack Elias to receive US patent for pulmonary fibrosis treatments April 20, 2023
Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings April 17, 2023
Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics April 13, 2023
TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel March 29, 2023
Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology March 21, 2023
Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation March 16, 2023
